OLK Olink Holding AB (publ) Stock Quote

OLK [NASD]

Healthcare | Diagnostics & Research | Sweden

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	69.86%	Shs Outstand	119.01M	Perf Week	31.28%
Market Cap	1.98B	Forward P/E	-	EPS next Y	-0.12	Insider Trans	0.00%	Shs Float	35.68M	Perf Month	37.74%
Income	-36.10M	PEG	-	EPS next Q	-0.12	Inst Own	38.90%	Short Float	11.61%	Perf Quarter	-11.23%
Sales	104.00M	P/S	19.00	EPS this Y	-79.70%	Inst Trans	4.75%	Short Ratio	19.66	Perf Half Y	-11.32%
Book/sh	3.82	P/B	4.47	EPS next Y	-	ROA	-6.60%	Target Price	18.33	Perf Year	-48.62%
Cash/sh	1.04	P/C	16.44	EPS next 5Y	-	ROE	-7.40%	52W Range	8.39 - 38.78	Perf YTD	-6.15%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-7.50%	52W High	-55.96%	Beta	-
Dividend %	-	Quick Ratio	5.10	Sales past 5Y	-	Gross Margin	60.50%	52W Low	103.58%	ATR	1.36
Employees	416	Current Ratio	6.20	Sales Q/Q	66.90%	Oper. Margin	-45.20%	RSI (14)	74.97	Volatility	15.13% 10.68%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	34.60%	Profit Margin	-34.70%	Rel Volume	1.06	Prev Close	16.22
Shortable	No	LT Debt/Eq	0.01	Earnings	May 12 BMO	Payout	-	Avg Volume	210.66K	Price	17.08
Recom	2.00	SMA20	46.86%	SMA50	40.66%	SMA200	-6.95%	Volume	223,994	Change	5.30%

Apr-19-21

Initiated

SVB Leerink

Outperform

$50

Apr-19-21

Initiated

Morgan Stanley

Equal-Weight

Apr-19-21

Initiated

Goldman

Neutral

$42

Apr-19-21

Initiated

BTIG Research

Buy

$44

Jun-28-22 08:00AM	Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight GlobeNewswire +8.33%
Jun-21-22 08:00AM	UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research GlobeNewswire
Jun-20-22 07:41AM	Olink Holding AB publ Sponsored ADR (OLK) Surges 7.3%: Is This an Indication of Further Gains? Zacks
Jun-16-22 08:00AM	Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies GlobeNewswire
Jun-14-22 09:33AM	Olink Holding AB (publ) (NASDAQ:OLK): When Will It Breakeven? Simply Wall St.
Jun-13-22 08:00AM	FinnGen selects Olink to accelerate leading Population Health Study GlobeNewswire -10.78%
Jun-08-22 08:00AM	Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics PR Newswire
Jun-07-22 08:00AM	Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read sequencing kits GlobeNewswire
08:00AM	Element Biosciences and Olink collaborate to enable Olink® Explore on the Element AVITI System GlobeNewswire
Jun-02-22 08:00AM	Pharma Foods International and Olink initiate strategic partnership in Japan GlobeNewswire +11.97%
Jun-01-22 08:00AM	Olink to participate in the 43rd Annual Goldman Sachs Global Healthcare Conference GlobeNewswire
May-15-22 08:17AM	Olink Holding AB (publ) (NASDAQ:OLK) Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St.
May-12-22 08:25AM	Olink Holding AB publ Sponsored ADR (OLK) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:00AM	Olink reports first quarter 2022 financial results GlobeNewswire
May-09-22 08:00AM	University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of disease GlobeNewswire -11.37%
May-04-22 01:08PM	Companies Like Olink Holding (NASDAQ:OLK) Are In A Position To Invest In Growth Simply Wall St.
Apr-21-22 08:00AM	Olink to report first quarter 2022 financial results on May 12, 2022 GlobeNewswire
Apr-07-22 04:05PM	Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022 GlobeNewswire
Mar-29-22 04:01PM	Olink Holding (NASDAQ:OLK) adds US$114m to market cap in the past 7 days, though investors from a year ago are still down 44% Simply Wall St. +5.22%
Mar-17-22 08:30AM	Olink publishes 2021 annual report GlobeNewswire +5.15%
Mar-09-22 08:00AM	TATAA Biocenter partners with Olink to add high quality proteomics with unrivaled throughput to their multi-omics offering GlobeNewswire +12.14%
Mar-07-22 08:00AM	THE NOMINATION COMMITTEES PROPOSAL FOR ELECTION OF MEMBERS OF THE BOARD OF DIRECTORS OF OLINK HOLDING AB (PUBL) GlobeNewswire
Feb-15-22 05:03PM	8 Medical Stocks to Buy According to Mitchell Blutts Consonance Capital Insider Monkey
Feb-14-22 07:00AM	Olink reports fourth quarter and full year 2021 financial results and provides outlook for 2022 GlobeNewswire -6.74%
Feb-01-22 08:00AM	Olink to present at February investor conferences GlobeNewswire +8.41%
Jan-21-22 02:30AM	Nasdaqs European Markets Delivered Record Year in 2021 GlobeNewswire
Jan-20-22 08:00AM	Sequanta selects Olink® Explore 3072 to analyze new cohort study in China GlobeNewswire +6.81%
Jan-10-22 06:02PM	Why Olink Holding Stock Blasted Higher Today Motley Fool +23.80%
08:00AM	Olink announces preliminary unaudited revenue for the fourth quarter and full year 2021 GlobeNewswire
Jan-04-22 08:00AM	Olink to present at the 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire -11.06%
Dec-23-21 01:38PM	MainStay VP Small Cap Growth Portfolio Buys Option Care Health Inc, Leslies Inc, Kratos Defense ... GuruFocus.com
Dec-06-21 08:00AM	Innovation and transparency at the heart of Olinks culture details of the technology behind the Olink Explore high-throughput proteomics platform published in the journal, Molecular & Cellular Proteomics GlobeNewswire
Dec-02-21 08:00AM	Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure GlobeNewswire
Dec-01-21 08:00AM	Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery GlobeNewswire -6.15%
Nov-29-21 09:00AM	Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France GlobeNewswire
Nov-23-21 08:00AM	Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olinks multiplex protein analysis platform GlobeNewswire
Nov-11-21 08:00AM	Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies GlobeNewswire
Nov-10-21 07:00AM	Olink reports third quarter 2021 financial results GlobeNewswire -13.55%
05:02AM	Fulgent Genetics, Inc. Common Stock (FLGT) Q3 2021 Earnings Call Transcript Motley Fool
Nov-05-21 07:00AM	Olink announces participation in November investor events GlobeNewswire
Nov-04-21 09:00AM	Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform GlobeNewswire
Oct-20-21 08:00AM	Olink to report third quarter 2021 financial results on November 10, 2021 GlobeNewswire
Sep-14-21 01:01AM	Is Olink Holding AB (OLK) A Good Stock To Buy Now? Insider Monkey
Sep-01-21 07:00AM	Olink to present at two upcoming investor conferences GlobeNewswire
Aug-31-21 07:00AM	CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services GlobeNewswire
Aug-11-21 07:00AM	Olink reports second quarter 2021 financial results GlobeNewswire -6.45%
Jul-27-21 07:00AM	Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for neurological diseases GlobeNewswire
Jul-20-21 10:41PM	Is Olink Holding AB (publ) (OLK) A Good Stock To Buy? Insider Monkey
Jul-14-21 10:45PM	Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders GlobeNewswire
Jul-13-21 08:00AM	Olink enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform GlobeNewswire -10.92%
Jul-12-21 04:31PM	Olink announces preliminary financial results for the second quarter 2021 GlobeNewswire
04:30PM	Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders GlobeNewswire
Jun-25-21 05:22AM	We're Not Worried About Olink Holding's (NASDAQ:OLK) Cash Burn Simply Wall St.
Jun-23-21 07:00AM	Olink announces the new Explore 3072 high throughput proteomics platform, offering uncompromised data quality with coverage of all major biological pathways GlobeNewswire
Jun-15-21 09:00AM	Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling GlobeNewswire -5.68%
Jun-02-21 07:00AM	Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedicated to multiplex protein biomarker measurement GlobeNewswire +5.71%
May-25-21 05:00PM	Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference GlobeNewswire
May-20-21 07:00AM	Olink reports first quarter 2021 financial results and issues full year 2021 guidance GlobeNewswire +9.08%
06:15AM	Olink Holding AB (publ) - ADR to Host Earnings Call ACCESSWIRE
May-04-21 08:00AM	Olink announces first core lab running the Olink Explore platform in Europe, making it available for more researchers GlobeNewswire
Apr-29-21 08:30AM	Olink to Report First Quarter 2021 Financial Results on May 20, 2021 GlobeNewswire -5.06%
Mar-25-21 07:11PM	5 of Thursdays 6 IPOs Fall Below Offer Prices Barrons.com
Mar-24-21 10:00PM	Olink Holding AB (publ) Announces Pricing of Initial Public Offering GlobeNewswire

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience